Posted On: 12/26/2014 10:31:42 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: biotechexpert #13923
Gerald is a serial diluted - sad but true. You simply can not tell your shareholders that you are creating shareholder value and appreciation while more than doubling the float each and every year - and not providing revenue simultaneously. It's like speaking out of both side of your mouth. That said, I hope Gerald lands size able and sustaining revenue on LymPro soon.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)